Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A. G. Zalevskaya"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 53-64 (2019)
Background. GP40041 is a biosimilar to Humulin® NPH. GP40041 is registered and administrated in Russia since 2004. However, due to changes in the regulatory requirements for biosimilar insulin development programme, we have conducted additional clin
Externí odkaz:
https://doaj.org/article/9d2dc92ffeba4d48a9212747e6142b86
Autor:
D. G. Zalevskaya, A Y Yakovlev
Publikováno v:
RUDN Journal of Public Administration, Vol 5, Iss 4, Pp 426-432 (2018)
In this article author examines the history of public administration of book publishing since the birth of mass printing in the middle of the XVI century to the stagnant crisis of 1980s. During this period of time the national book publishing has cha
Externí odkaz:
https://doaj.org/article/2e74194ce8a04a43ab2a7b2b84c3f4e6
Autor:
Nataliya S. Novoselova, Anna A. Mosikian, Olga Y. Martyanova, Evgenya M. Patrakeeva, Alsu G. Zalevskaya
Publikováno v:
Сахарный диабет, Vol 21, Iss 6, Pp 472-479 (2018)
Background: Only a little percent of chronically ill patients was found to follow physicians’ prescriptions. One of the reasons for this issue is misunderstanding of recommendations due to inappropriate interpretation of medical terms, contained in
Externí odkaz:
https://doaj.org/article/e2b806c8604a4e359177949b3b2458fe
Autor:
Klemen Dovc, Gül Yeşiltepe Mutlu, Yury I. Philippov, Dmitry N. Laptev, Evgenia M. Patrakeeva, Lubov O. Chernilova, Alsu G. Zalevskaya, Marina V. Shestakova, Tadej Battelino
Publikováno v:
Сахарный диабет, Vol 21, Iss 3, Pp 206-216 (2018)
BACKGRAUND: A closed-loop glucose control system or ‘artificial pancreas’ consists of three components – a Continuous Glucose Monitor (CGM), infusion pumps to deliver hormone(s) and a sophisticated dosing algorithm to control hormone delivery.
Externí odkaz:
https://doaj.org/article/bb3b843fbf3f4df295dbcc4833fa4fb2
Autor:
S. R. Aravind, Kiran P. Singh, Liliia Mogylnytska, Alsu G. Zalevskaya, Beata Matyjaszek-Matuszek, Karin Wernicke-Panten, My-Liên Nguyên-Pascal, Suzanne Pierre, Baerbel Rotthaeuser, Daniel Kramer, Bhaswati Mukherjee
Publikováno v:
Diabetes Therapy. 13:1299-1310
We compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (70% intermediate SAR341402 protamine and 30% rapid SAR341402 solution) (SARThis phase 3, randomized, open-label, multinational, 26-week tria
Autor:
S. R. Aravind, Kiran P. Singh, Grace Aquitania, Liliia Mogylnytska, Alsu G. Zalevskaya, Beata Matyjaszek-Matuszek, Karin Wernicke-Panten, My-Liên Nguyên-Pascal, Suzanne Pierre, Baerbel Rotthaeuser, Daniel Kramer, Bhaswati Mukherjee
Publikováno v:
Diabetes therapy : research, treatment and education of diabetes and related disorders. 13(5)
This study compared the efficacy, safety, and immunogenicity of biosimilar insulin aspart premix SAR341402 Mix 70/30 (SARThis 26-week, open-label, phase 3 trial enrolled 402 people with T1D (n = 105) or T2D (n = 297) previously treated with premix in
Autor:
A G Zalevskaya, E M Patrakeeva
Publikováno v:
Сахарный диабет, Vol 11, Iss 4, Pp 12-17 (2008)
Общеизвестным фактом является высокая распро страненность и растущая частота сахарного диабета 2 типа (СД2), ожирения, сопутствующих им
Autor:
A G Zalevskaya, E M Patrakeeva
Publikováno v:
Ожирение и метаболизм, Vol 4, Iss 1, Pp 2-7 (2007)
Publikováno v:
"Arterial’naya Gipertenziya" ("Arterial Hypertension"). 9:54-58
To evaluate the efficiency of treatment in obese patients with educating methods, 73 patients were examined A protocol of examination included the estimation of anthropometric indices, the measurement of blood pressure, the levels of glucose and insu